Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN
1 clinical trials · Condition
◉ Watch Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN
| Record | Firm | Date |
|---|---|---|
| Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical Trial (NCT07165769) | Institute of Hematology & Blood Diseases Hospital, China | 2025-09-04 |
Track Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN automatically
Every clearance here is in the API, with alerts when new ones post.